Live Breaking News & Updates on Pascal Schmidt

Stay updated with breaking news from Pascal schmidt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

21st Austria weekly - Marinomed (22/05/2024)

21st Austria weekly - Marinomed 22/05/2024 [pic1]Marinomed: Biotech AG VSE:MARI announces revenues of EUR 0.7 million recorded in the first quarter 2024. After observing record from Carragelose product sales heavily influenced by SARS-CoV-2 pandemic over past years revenue 2024 has declined to levels observed before pandemic. This decline is mostly due high inventories and return seasonality causing a drop customer demand. Due cost-conscious cash management equivalents stood at 1.9 compared 2.6 end 2023. The operating result EBIT -1.9 Q1 2023: -1.4 million loss for period amounted -2.1 million. “Although we are making constant progress working on several initiatives parallel situation remains challenging. Revenues ....

Zumtobel Gruppe , Pascal Schmidt , Marinomed Biotech , Besuchen Sie ,

Marinomed Biotech AG announces results for the first quarter of 2024

EQS-News: Marinomed Biotech AG


/ Key word: Quarter Results





Marinomed Biotech AG announces results for the first quarter of 2024






22.05.2024 / 07:45 CET/CEST



The issuer. ....

Pascal Schmidt , Andreas Grassauer , Eva Ruppnig , Lucia Ziegler , International Media Contact , Vienna Stock Exchange , Metrum Communications , Procter Gamble , Marinomed Biotech ,

21st Austria weekly - Marinomed, Agrana, A1 Telekom Austria (16/04/2024)

21st Austria weekly - Marinomed Agrana A1 Telekom 16/04/2024 [pic1]Agrana: Fruit starch sugar company Agrana generated operating profit EBIT of € 151.0 million in its 2023|24 financial year 1 March 2023 to 29 February 2024 which is line with guidance a very significant improvement compared the prior 2022|23: 88.3 million. Earnings per share rose 1.04 prior year: 0.25. Consolidated revenue amounted 3 786.9 3 637.4 As previously communicated Q3 results published January 2024 sees itself confronted an increasingly challenging business environment since fourth quarter and forecasts EBIT for 2024|25 will be significantly below comparable figure 2023|24. This decline already become apparent first 2024|25.Agrana: performance: -0.74% Marinomed: Marinomed ....

Pascal Schmidt , Alejandro Plater , Warimpex Finanz , Errichtung Von Hotels , European Investment Bank , Marinomed Biotech , Besuchen Sie ,